Clinical Trial Detail

NCT ID NCT01729923
Title A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors University of Washington
Indications

colorectal cancer

Therapies

Capecitabine

Celecoxib

Age Groups: adult

No variant requirements are available.